Portfolio

Investing where others aren’t looking yet.

A selection of the leaves on our branches — companies chosen by the same disciplined process, each placed where disruption was still a rumor.

Thank you for reading this post, don't forget to subscribe!
O 2024

Orahealth

Specialty care network scaling across a fragmented market.

WHY WE INVESTEDA care organization consolidating a fragmented market, with durable demand and operating leverage the index has no clean way to capture.

SPECIALTY & MULTI-SITE CARE
A 2025

Athyna AI

Technology-native global talent and staffing infrastructure.

WHY WE INVESTEDTechnology-native delivery in a labor-cost arbitrage market — a margin structure legacy staffing firms structurally cannot match.

AI AGENTS & OPERATIONS
P 2026

Path Robotics

Autonomous robotic welding for advanced manufacturing.

WHY WE INVESTEDA hard-tech moat in a labor-constrained industry where automation has crossed from optional to inevitable.

INDUSTRIAL ROBOTICS & AUTOMATION
S 2026

Samply

Sampling and field-research data infrastructure.

WHY WE INVESTEDAn infrastructure layer for a workflow every research team needs but no incumbent has bothered to standardize.

RESEARCH & DATA INFRASTRUCTURE
B 2024

Babyvend EXIT

Automated retail for parents. Acquired by Levels.

WHY WE INVESTEDAutomated retail with unit economics that compounded quietly until they became a strategic acquisition.

CONSUMER
Full position memos — thesis, structure, and terms — are shared with qualified investors in the investor room. Request access →